The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
Abstract
Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA) clinical trials, as well as to recommend specific methods for assessing each outcome measure. This is not intended to be a restrictive list, but rather, a core set of measures that should be included in all trials. Methods. We evaluated disease activity measures commonly used in RA trials, to determine which measures best met each of 5 types of validity: construct, face, content, criterion, and discriminant. The evaluation consisted of an initial structured review of the literature on the validity of measures, with an analysis of data obtained from clinical trials to fill in gaps in this literature. A committee of experts in clinical trials, health services research, and biostatistics reviewed the validity data. A nominal group process method was used to reach consensus on a core set of disease activity measures. This set was then reviewed and finalized at an international conference on outcome measures for RA clinical trials. The committee also selected specific ways to assess each outcome. Results. The core set of disease activity measures consists of a tender joint count, swollen joint count, patient's assessment of pain, patient's and physician's global assessments of disease activity, patient's assessment of physical function, and laboratory evaluation of 1 acute‐phase reactant. Together, these measures sample the broad range of improvement in RA (have content validity), and all are at least moderately sensitive to change (have discriminant validity). Many of them predict other important long‐term outcomes in RA, including physical disability, radiographic damage, and death. Other disease activity measures frequently used in clinical trials were not chosen for any one of several reasons, including insensitivity to change or duplication of information provided by one of the core measures (e.g., tender joint score and tender joint count) The committee also proposes specific ways of measuring each outcome. Conclusion. We propose a core set of outcome measures for RA clinical trials. We hope this will decrease the number of outcomes assessed and standardize outcomes assessments. Further, we hope that these measures will be found useful in long‐term studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes
(1976) · The Journal of Applied Behavioral Science · doi:10.1177/002188637601200414 · Cited by 2,813
(1968) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067150 · Cited by 1,349
Measuring health status in arthritis
Meenan, R. F., Gertman, P. M., & Mason, J. H. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230203 · Cited by 1,176
van der Heijde, D. M., van 't Hof, M. A., van Riel, P. L., Theunisse, L. A., Lubberts, E. W., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.11.916 · Cited by 1,087
Pincus, T., Callahan, L. F., Sale, W. G., Brooks, A. L., Payne, L. E., & Vaughn, W. K. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270805 · Cited by 760
The Effectiveness of Nominal, Delphi, and Interacting Group Decision Making Processes.
Van de, A. H., & Delbecq, A. L. (1974) · Academy of Management Journal · doi:10.2307/255641 · Cited by 695
Survival, prognosis, and causes of death in rheumatoid arthritis
Mitchell, D. M., Spitz, P. W., Young, D. Y., Bloch, D. A., McShane, D. J., & Fries, J. F. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290602 · Cited by 431
Tugwell, P., Bombardier, C., Buchanan, W. W., Goldsmith, C. H., Grace, E. M., & Hanna, B. (1987) · PubMed · Cited by 390
Self-citationBombardier, C., Ware, J., Russell, I. J., Larson, M., Chalmers, A., Read, J. L., Arnold, W., Bennett, R., Caldwell, J., Hench, P. K., et al. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90539-5 · Cited by 359
Self-citationvan der Heijde, D. M., van't Hof, M. A., van Riel, P. L., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.2.177 · Cited by 325
Outcome assessment in clinical trials evidence for the sensitivity of a health status measure
Meenan, R. F., Anderson, J. J., Kazis, L. E., Egger, M. J., Altz‐Smith, M., Samuelson, C. O., Willkens, R. F., Solsky, M. A., Hayes, S. P., Blocka, K. L., et al. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780271204 · Cited by 247
Self-citationA Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritis
Mainland, D. (1965) · Arthritis & Rheumatism · doi:10.1002/art.1780080214 · Cited by 242
Pincus, T., Callahan, L. F., Brooks, R. H., Fuchs, H. A., Olsen, N. J., & Kaye, J. J. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-4-259 · Cited by 234
The assessment and prediction of functional disability in rheumatoid arthritis.
Wolfe, F., & Cathey, M. A. (1991) · PubMed · Cited by 231
Self-citationPrediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.
Möttönen, T. T. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.8.648 · Cited by 223
Chambers, L. W., Macdonald, L. A., Tugwell, P., Buchanan, W. W., & Kraag, G. (1982) · PubMed · Cited by 211
Self-citationDawes, P. T., Fowler, P. D., Clarke, S., FISHER, J., LAWTON, A., & Shadforth, M. F. (1986) · Rheumatology · doi:10.1093/rheumatology/25.1.44 · Cited by 151
Pincus, T., Callahan, L. F., & Wk, V. (1987) · PubMed · Cited by 149
Which traditional measures should be used in rheumatoid arthritis clinical trials?
Anderson, J. J., Felson, D. T., Meenan, R. F., & Williams, H. J. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320907 · Cited by 138
Self-citationMethotrexate in Rheumatoid Arthritis
Tugwell, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.1.59 · Cited by 137
Self-citationCause and age at death in a prospective study of 100 patients with rheumatoid arthritis.
Rasker, J. J., & Cosh, J. (1981) · Annals of the Rheumatic Diseases · doi:10.1136/ard.40.2.115 · Cited by 136
A methodologic framework for developing and selecting endpoints in clinical trials.
Tugwell, P., & Bombardier, C. (1982) · PubMed · Cited by 136
Self-citationWolfe, F., Hawley, D. J., & Cathey, M. A. (1991) · PubMed · Cited by 110
Self-citationHawley, D. J., & Wolfe, F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1790050304 · Cited by 107
Self-citationMortality predictors among 263 patients with rheumatoid arthritis.
Leigh, J. P., & Fries, J. F. (1991) · PubMed · Cited by 107
SENSITIVITY OF A HEALTH STATUS MEASURE TO SHORT‐TERM CLINICAL CHANGES IN ARTHRITIS
Anderson, J. J., Firschein, H. E., & Meenan, R. F. (1989) · Arthritis & Rheumatology · doi:10.1002/j.2326-5205.1989.tb00015.x · Cited by 96
Self-citationAn experiment in reducing interobserver variability of the examination for joint tenderness.
Av, K., Bellamy, N., Bombardier, C., Carette, S., Chalmers, A., Esdaile, J. M., Goldsmith, C. H., Tugwell, P., SMYTHE, H. A., & Ww, B. (1988) · PubMed · Cited by 93
Self-citationThe role of evidence in the consensus process. Results from a Canadian consensus exercise
Lomas, J. (1988) · JAMA · doi:10.1001/jama.259.20.3001 · Cited by 90
G∅tzsche, P. C. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90097-9 · Cited by 88
A comparison of health-related quality-of-life measures for rheumatoid arthritis research
Bombardier, C., & Raboud, J. (1991) · Controlled Clinical Trials · doi:10.1016/s0197-2456(05)80028-5 · Cited by 86
Self-citationLiang, M. H., Katz, J. N., Phillips, C., Sledge, C. B., & Cats‐Baril, W. L. (1991) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199173050-00001 · Cited by 84
Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis.
Leigh, J. P., & Fries, J. F. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.5.581 · Cited by 78
EFFICACY OF TESTS USED TO MONITOR RHEUMATOID ARTHRITIS
Bull, B. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90965-3 · Cited by 63
Reduced joint count indices in the evaluation of rheumatoid arthritis
Egger, M. J., Huth, D. A., Ward, J. R., Reading, J. C., & Williams, H. J. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280603 · Cited by 62
Thompson, P. W., Hart, L. E., Goldsmith, C. H., Spector, T. D., Bell, M. J., & Ramsden, M. F. (1991) · PubMed · Cited by 57
Self-citationBellamy, N., Carette, S., Ford, P. M., Kean, W. F., le Riche, N. G., Lussier, A., Wells, G. A., & Campbell, J. (1991) · PubMed · Cited by 50
van der Heijde, D. M. F. M., van Riel, P. L. C. M., & van de Putte, L. B. A. (1990) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749009097629 · Cited by 44
Health status as a predictor of mortality in rheumatoid arthritis: a five-year study.
Kazis, L. E., Jj, A., & Meenan, R. F. (1990) · PubMed · Cited by 43
Herbert, T. T., & Yost, E. B. (1979) · Decision Sciences · doi:10.1111/j.1540-5915.1979.tb00031.x · Cited by 39
The impact of endpoint measures in rheumatoid arthritis clinical trials
van der Heide, A., Jacobs, J. W. G., Dinant, H. J., & Bijlsma, J. W. J. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90022-6 · Cited by 37
Gb, L., & Sheppeard, H. (1985) · PubMed · Cited by 37
Cited by
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationAmerican college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Self-citationEfficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Treating rheumatoid arthritis to target: recommendations of an international task force
Smolen, J. S., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123919 · Cited by 2,100
Metadata
- Authors
- Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., Paulus, H., Tugwell, P., Weinblatt, M., Widmark, R., James Williams, H., & Wolfe, F.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1993-06
- Volume
- 36
- Issue
- 6
- Pages
- 729-740
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2033299724
- Cited by
- 1,640
- References
- 41
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.